These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
    Author: Gates GA, Green JD.
    Journal: Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267.
    Abstract:
    HYPOTHESIS: Treatment with the Meniett device, which applies intermittent micropressure pulses to the inner ear through a tympanostomy tube, is effective in controlling vertigo in people with intractable Ménière's disease. STUDY DESIGN: Short-term, preliminary descriptive report. METHODS: Ten patients with intractable vertigo despite adequate medical therapy elected to use the Meniett device. After placement of a standard tympanostomy tube, the patient self-administers the Meniett device three times daily. RESULTS: The follow-up ranged from 3 to 11 months with an average of 8 months. All 10 patients responded to the therapy with vertigo control in 9 of 10 and a 50% reduction in the 10th case. There was a mean hearing gain of 6 dB, which was statistically significant. There were no major complications. Two subjects required tube reinsertion during the 8 months of follow-up. CONCLUSIONS: Use of the Meniett device is an effective and safe option for people with intractable vertigo from Ménière's disease.
    [Abstract] [Full Text] [Related] [New Search]